XML 52 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT REPORTING
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
Our reportable segments are described below:

Imaging Center

Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. We also provide teleradiology services in the United Kingdom though our majority-owned Heart & Lung Imaging Limited subsidiary. Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.
Artificial Intelligence ("AI")

Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP. We do not report balance sheet information by segment since it is not reviewed by our CODM.

In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.

Twelve Months Ended December 31, 2023
Imaging CentersAIIntersegment EliminationConsolidated Total
Revenue:
Third Party$1,610,707 $5,923 $— $1,616,630 
Intersegment— 6,546 (6,546)— 
Total revenue$1,610,707 $12,469 $(6,546)$1,616,630 


Twelve Months Ended December 31, 2022
Imaging CentersAIIntersegment EliminationConsolidated Total
Revenue:
Third Party$1,425,665 $4,396 $— $1,430,061 
Intersegment— — — — 
Total revenue$1,425,665 $4,396 $— $1,430,061 

The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):
Twelve Months Ended December 31,
202320222021
Revenue:
Imaging Centers$1,604,161 $1,425,665 $1,313,662 
AI12,469 4,396 1,415 
Total revenue$1,616,630 $1,430,061 $1,315,077 
Cost of Operations
Imaging Centers$1,371,036 $1,240,593 $1,117,941 
AI24,203 23,753 5,333 
Total cost of operations$1,395,239 $1,264,346 $1,123,274 
Gain on contribution of imaging centers into joint venture
Imaging Centers$(16,808)$— $— 
AI— — — 
Total cost of operations$(16,808)$— $— 
Lease abandonment charges
Imaging Centers$5,146 $— $19,675 
AI— — — 
Total depreciation and amortization$5,146 $— $19,675 
Depreciation and Amortization
Imaging Centers$120,776 $109,524 $96,174 
AI7,615 6,353 520 
Total depreciation and amortization$128,391 $115,877 $96,694 
Loss on Disposal of Equipment
Imaging Centers$2,191 $2,506 $1,246 
AI(4)23 — 
Total loss (gain)$2,187 $2,529 $1,246 
Severance
Imaging Centers$1,973 $926 $744 
AI1,805 20 — 
Total severance$3,778 $946 $744 
Income from Operations
Imaging Centers$119,847 $72,116 $77,882 
AI(21,150)(25,753)(4,438)
Total income from operations$98,697 $46,363 $73,444 
In the first quarter of 2024, we revised our reportable segments to combine our eRad business, which was included in the Imaging Center segment, with our AI segment to form a new Digital Health reportable segment. As a result of the change, beginning with our Quarterly Report on Form 10-Q for the quarter ending March 31, 2024, we will report our results in these two reportable segments. The change in reportable segments will be reflected retrospectively.